Articles By This Author
Medical Q&A platform Ask The Doctor files lawsuit against Shiba Inu, engages war of words on Twitter
Tuesdays can be boring, but an ongoing Twitter drama is captivating the attention of many blockchain enthusiasts. Ask The Doctor, a Canadian medical questions and
Micron CEO: supply chain bottlenecks are improving
Shares of Micron Technology Inc (NASDAQ: MU) are up nearly 10% this morning on market-beating Q1 results and strong guidance for the future. CEO Mehrotra’s
Will there be a Santa rally this year?
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Inside the Iranian Bitcoin mining industry
ViraMiner is an Iranian company that sets up Bitcoin mining farms and maintains them. It has two offices in western Tehran, located in separate adjacent
Best FAANG stocks to buy for 2022
The metaverse is one of the most promising places to look forward to going into the new year. Meta Platforms alongside Alphabet could benefit differently.
The political Santas and Grinches of the crypto industry in 2021
2021 was a huge year for the crypto industry. A few years ago, our elected officials probably hadn’t even heard of crypto before, let alone
Bank of Russia to allow crypto investment via foreign firms: Report
Russia continues sending mixed signals to the cryptocurrency markets as more reports provide details on the country’s upcoming crypto regulation. Shortly after Bank of Russia
Dormant Bitcoin wallet holding 321 BTC activated after eight years
A Bitcoin wallet containing millions of dollars worth of Bitcoin (BTC) has come out of dormancy. For one reason or another, the wallet has not
Blockchain startup sues Brian Armstrong for allegedly stealing its work
ResearchHub, a scientific research site founded and self-funded by Coinbase CEO Brian Armstrong, is allegedly based on work stolen from its not-launched competitor, a new
Where to buy the current Moderna (MRNA) stock dip
Moderna stock is currently on a pullback but analysts believe the dip is short-lived especially due to the ongoing fight against the recent Omricon Covid-19